Trial Glossary

LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
AALL0232	A trial investigating high dose methotrexate compared with escalating Capizzi methotrexate plus asparaginase in newly diagnosed patients with high-risk B-cell precursor acute lymphoblastic leukaemia who had previously received prednisone or dexamethasone as induction/consolidation therapy
AML 16	A trial looking at treatment for acute myeloid leukaemia and high risk myelodysplastic syndrome
CLASSIC	A trial investigtating clofarabine plus cytarabine versus cytarabine alone in older patients with relapsed or refractory acute myelogenous leukaemia
COSMIC	A phase II, multi-centre, randomised, open, parallel group trial investigating combination fludarabine and cyclophosphamide plus ofatumumab at standard or mega dose in chronic lymphoid leukemia (CLL)
DASA-TRAS	A pilot study investgating the efficacy and safety of dasatinib after allogeneic stem cell transplantation in patients with de novo Philadelphia positive (bcr-abl+) acute lymphoblastic leukemia
DASISION	A trial investigating dasatinib versus imatinib in chronic phase chronic myeloid leukaemia
ENESTnd	A trial comparing nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia
Leukaemia Lymphoma Research and NCRI Working Group Pick a Winner Programme (LI-1) Trial	A multicentre phase II/III interventional study comparing standard care treatment for acute myeloid leukaemia patients over the age of 60 not fit for intensive chemotherapy in combination with novel agents versus novel agents alone
ML 17	A trial looking at treatment for acute promyelocytic and acute myeloid leukaemias
DEC-MDS	A trial looking at decitabine for myelodysplastic syndrome and acute myeloid leukaemia
FB - ATG	A trial looking at mini stem cell transplants for myelodysplastic syndrome and acute myeloid leukaemia
MARALL	A study looking at adding a type of biological therapy to chemotherapy for acute lymphoblastic leukaemia that has come back after treatment
PICCLe	A Phase I/II clinical trial investigating the efficacy and safety of olaparib, a poly (ADP-ribose) polymerase (PARP) -inhibitor, in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia and mantle cell lymphoma
The CONTINUUM Trial	A trial looking at lenalidomide (Revlimid) for B cell chronic lymphocytic leukaemia that has responded to second line chemotherapy
UKALL 2003	A trial looking at chemotherapy for children and young people with acute lymphoblastic leukaemia
LYMPHOMA
CHOP-CAMPATH	A study of CHOP and Campath for peripheral T cell lymphoma
EMERGE	A trial looking at lenalidomide for mantle cell lymphoma
FORT	A trial looking at radiotherapy for people with follicular lymphoma or marginal zone lymphoma
GemBex	A trial looking at gemcitabine and bexarotene for people with T cell lymphoma of the skin
MCL MiniAllo	A trial of low intensity transplants for mantle cell lymphoma
PACIFICO	A trial looking at rituximab and chemotherapy as a treatment for follicular lymphoma in elderly patients
PAIReD	A trial looking at high dose chemotherapy and stem cell transplants for people with Hodgkin's lymphoma
PRIMA	A trial investigating the benefit of maintenance therapy with rituximab as measured by progression-free survival (PFS) compared with no maintenance therapy after induction of response with chemotherapy plus rituximab in patients with high tumor burden follicular lymphoma
PROPEL	A trial investigating whether pralatrexate injection may reverse the pattern of progressive resistance observed in patients with relapsed or refractory peripheral T-cell lymphoma
RATHL	A trial looking at PET scans and treatment for Hodgkin's lymphoma
R-CHOP 14 vs R-CHOP 21	A trial looking at treatment every 2 weeks or every 3 weeks for non Hodgkin's lymphoma
R-CODOX-M/IVAC for DLBCL or BL	A trial looking at chemotherapy and rituximab for people with diffuse large B cell non Hodgkin's lymphoma or Burkitt's lymphoma
ReACH	A trial looking at high dose chemotherapy and stem cell transplants for people with Hodgkin's lymphoma that has come back for the first time
RIC UCBT	A trial of stem cell transplants using umbilical cord blood
SPIRIT 2	A trial looking at imatinib and dasatinib for newly diagnosed chronic myeloid leukaemia
SWOG S9704	A trial investigating autologous stem-cell transplantation in patients with high-intermediate or high International Prognostic Index risk diffuse aggressive non-Hodgkin’s lymphoma who have objective responses to cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP)-based induction therapy
The 18 to 30 study	A trial looking at chemotherapy for young people with Hodgkin's lymphoma
TOPPS	A trial looking at platelet transfusions during treatment for cancer of the blood or lymphatic system
MYELOMA
ADMYRE	A trial of plitidepsin in combination with dexamethasone versus dexamethasone alone in patients with relapsed/refractory multiple myeloma
CAFE	A trial investigating the use of balloon kyphoplasty, a minimally invasive surgical procedure to treat vertebral compression fracture in myeloma patients
CALGB 100104 study	IFM 2005-02: a trial comparing lenalidomide maintenance therapy or no maintenance post high dose melphalan with peripheral blood stem cell support in younger patients
ELOQUENT – 1	A Phase III study of lenalidomide and dexamethasone with or without elotuzumab to treat newly diagnosed, previously untreated multiple myeloma
LenaRIC	A Phase II study of the adjuvant use of lenalidomide in patients undergoing reduced intensity conditioning allogenic transplantation for multiple myeloma
MM5	A trial investigating two regimens of bortezomib-based induction therapy and of lenalidomide consolidation followed by lenalidomide maintenance treatment in patients with multiple myeloma
MMIFTT	A trial looking at DNA vaccine therapy after stem cell transplant for myeloma
MRC Myeloma IX trial	A trial investigating first-line treatment with zoledronic acid versus clodronic acid in newly diagnosed multiple myeloma patients
MUKone	An open label, multicentre, randomised, parallel group phase II selection trial to identify the optimal starting dose of bendamustine (60 versus 100 mg/m2) when given in combination with thalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
MUK three	A trial investigating CHR-3996, a histone deacetylase inhibitor, in combination with tosedostat in subjects with multiple myeloma
Myeloma X Relapse	A trial looking at a second stem cell transplant for people whose myeloma has come back following a previous transplant
PADIMAC	A trial investigating progression-free survival in multiple myeloma for patients who receive no further treatment after achieving a major response to induction therapy with PAD (Bortezomib, Adriamycin and Dexamethasone)
TEAMM	A randomized, double-blind, placebo-controlled multi-centre phase III clinical trial assessing the benefit of antibiotic prophylaxis and its effect on health care associated infections in newly diagnosed myeloma

Haematology Now

Trial Glossary